Having co-morbid cardiovascular disease at time of cancer diagnosis: already one step behind when it comes to HRQoL?

References

• Ogle KS, Swanson GM, Woods N, et al. Cancer and comorbidity: redefining chronic diseases. Cancer. 2000;88:653–663.
   PubMed Web of Science ®Google Scholar
• Janssen-Heijnen ML, Szerencsi K, van de Schans SA, et al. Cancer patients with cardiovascular disease have survival rates comparable to cancer patients within the age-cohort of 10 years older without cardiovascular morbidity. Critic Rev Oncol/Hematol. 2010;76:196–207.
   PubMed Web of Science ®Google Scholar
• Geiger S, Lange V, Suhl P, et al. Anticancer therapy induced cardiotoxicity: review of the literature. Anticancer Drugs. 2010;21:578–590.
   PubMed Web of Science ®Google Scholar
• Schimmel KJ, Richel DJ, van den Brink RB, et al. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev. 2004;30:181–191.
   PubMed Web of Science ®Google Scholar
• Lenihan DJ, Cardinale D, Cipolla CM. The compelling need for a cardiology and oncology partnership and the birth of the International CardiOncology Society. Prog Cardiovasc Dis. 2010;53:88–93.
   PubMed Web of Science ®Google Scholar
• Janssen-Heijnen ML, Houterman S, Lemmens VE, et al. Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Critic Rev Oncol/Hematol. 2005;55:231–240.
   PubMed Web of Science ®Google Scholar
• Vissers PA, Thong MS, Pouwer F, et al. The impact of comorbidity on Health-Related Quality of Life among cancer survivors: analyses of data from the PROFILES registry. J Cancer Surviv. 2013;7:602–613.
   PubMed Web of Science ®Google Scholar
• Schoormans D, Czene K, Hall P, et al. The impact of co-morbidity on health-related quality of life in breast cancer survivors and controls. Acta oncologica. 2015;54:727.
   PubMed Web of Science ®Google Scholar
• van de Poll-Franse LV, Horevoorts N, van Eenbergen M, et al. The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohorts. Eur J Cancer. 2011;47:2188–2194.
   PubMed Web of Science ®Google Scholar
• de Rooij BH, Ezendam NPM, Mols F, et al. Cancer survivors not participating in observational patient-reported outcome studies have a lower survival compared to participants: the population-based PROFILES registry. Qual Life Res. 2018;27:3313.
   PubMed Web of Science ®Google Scholar
• De Marco MF, Janssen-Heijnen ML, van der Heijden LH, et al. Comorbidity and colorectal cancer according to subsite and stage: a population-based study. Eur J Cancer. 2000;36:95–99.
   PubMed Web of Science ®Google Scholar
• Schouten LJ, Jager JJ, van den Brandt PA. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993;68:974–977.
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. Hoboken, NJ, USA: John Wiley & Sons; 2011.
   Google Scholar
• Sangha O, Stucki G, Liang MH, et al. The Self-Administered Comorbidity Questionnaire: a new method to assess comorbidity for clinical and health services research. Arthritis Rheum. 2003;49:156–163.
   PubMed Web of Science ®Google Scholar
• Arndt V, Koch-Gallenkamp L, Jansen L, et al. Quality of life in long-term and very long-term cancer survivors versus population controls in Germany. Acta oncologica. 2017;56:190–197.
   PubMed Web of Science ®Google Scholar
• Cocks K, King MT, Velikova G, et al. Evidence-based guidelines for determination of sample size and interpretation of the European Organisation for the Research and Treatment of Cancer Quality of Life Questionnaire Core 30. JCO. 2011;29:89–96.
   PubMed Web of Science ®Google Scholar
• Brown N, Melville M, Gray D, et al. Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart. 1999;81:352–358.
   PubMed Web of Science ®Google Scholar
• Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002;87:235–241.
   PubMed Web of Science ®Google Scholar
• Leuzzi C, Sangiorgi GM, Modena MG. Gender-specific aspects in the clinical presentation of cardiovascular disease. Fundam Clin Pharmacol. 2010;24:711–717.
   PubMed Web of Science ®Google Scholar
• Fleshner N, Herschorn S. The artificial urinary sphincter for post-radical prostatectomy incontinence: impact on urinary symptoms and quality of life. J Urol. 1996;155:1260–1264.
   PubMed Web of Science ®Google Scholar
• Garcia M, Mulvagh SL, Merz CN, et al. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118:1273–1293.
   PubMed Web of Science ®Google Scholar
• Schwarz R, Hinz A. Reference data for the quality of life questionnaire EORTC QLQ-C30 in the general German population. Eur J Cancer. 2001;37:1345–1351.
   PubMed Web of Science ®Google Scholar
• Netuveli G, Blane D. Quality of life in older ages. Br Med Bull. 2008;85:113–126.
   PubMed Web of Science ®Google Scholar
• Angelis CD. Side effects related to systemic cancer treatment: are we changing the Promethean experience with molecularly targeted therapies? Curr Oncol. 2008;15:198–199.
   PubMed Web of Science ®Google Scholar
• Kieszak SM, Flanders WD, Kosinski AS, et al. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol. 1999;52:137–142.
   PubMed Web of Science ®Google Scholar
• Lemmens VE, Janssen-Heijnen ML, Verheij CD, et al. Co-morbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg. 2005;92:615–623.
   PubMed Web of Science ®Google Scholar